The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome

[1]  K. Perisinakis,et al.  Association between increased levels of IL‐2 and IL‐15 and outcome in patients with early acute respiratory distress syndrome , 2002, European journal of clinical investigation.

[2]  K. Perisinakis,et al.  The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome , 2002, Respiratory research.

[3]  G. Bellingan.  The pulmonary physician in critical care • 6: The pathogenesis of ALI/ARDS , 2002, Thorax.

[4]  J. Pugin,et al.  Cytokine balance in the lungs of patients with acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.

[5]  J. Tomashefski.  Pulmonary pathology of acute respiratory distress syndrome. , 2000, Clinics in chest medicine.

[6]  G. Meduri,et al.  Cytokines IL-1 β , IL-6, and TNF- α EnhanceIn Vitro Growth of Bacteria , 1999 .

[7]  T. Martin,et al.  Lung cytokines and ARDS: Roger S. Mitchell Lecture. , 1999, Chest.

[8]  J. Devière,et al.  Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice , 1998, Gut.

[9]  J. Kienast,et al.  Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. , 1998, Critical care medicine.

[10]  E. Moore,et al.  Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. , 1998, The Journal of surgical research.

[11]  L. Armstrong,et al.  Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome. , 1997, Thorax.

[12]  G. Meduri,et al.  Infections and the inflammatory response in acute respiratory distress syndrome. , 1997, Chest.

[13]  P. Parsons,et al.  Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. , 1997, American journal of respiratory and critical care medicine.

[14]  R. Strieter,et al.  Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[15]  W. Seeger,et al.  Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. , 1996, The European respiratory journal.

[16]  M. Burdick,et al.  The Association between Mortality Rates and Decreased Concentrations of Interleukin-10 and Interleukin-1 Receptor Antagonist in the Lung Fluids of Patients with the Adult Respiratory Distress Syndrome , 1996, Annals of Internal Medicine.

[17]  F. Stentz,et al.  Clinical Investigations in Critical CareInflammatory Cytokines in the BAL of Patients With ARDS: Persistent Elevation Over Time Predicts Poor Outcome , 1995 .

[18]  J. Vincent,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.

[19]  J. Shelhamer,et al.  Airway Inflammation , 1995, Annals of Internal Medicine.

[20]  F. Stentz,et al.  Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS : plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time , 1995 .

[21]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[22]  P. Ward,et al.  Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. , 1993, Journal of immunology.

[23]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[24]  M. Matthay,et al.  Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. , 1992, The American review of respiratory disease.

[25]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[26]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[27]  D. Baldwin,et al.  Microlavage: a technique for determining the volume of epithelial lining fluid. , 1991, Thorax.

[28]  T. Calandra,et al.  High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. , 1991, The American journal of medicine.

[29]  Rinaldo Je,et al.  Mechanisms and mediators of the adult respiratory distress syndrome. , 1990 .

[30]  J. Grassi,et al.  Production of monoclonal antibodies against interleukin-1α and -1β: Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media , 1989 .

[31]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[32]  T. Petty,et al.  Adult respiratory distress syndrome: risk with common predispositions. , 1983, Annals of internal medicine.

[33]  P. Pepe,et al.  Clinical predictors of the adult respiratory distress syndrome. , 1982, American journal of surgery.

[34]  S. Headley,et al.  Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. , 1995, Chest.

[35]  J. Christman,et al.  Mechanisms and mediators of the adult respiratory distress syndrome. , 1990, Clinics in chest medicine.